SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending due to discussions around a potential short squeeze and unusual options activity, indicating bullish sentiment. Community members are debating the company's valuation and future prospects in the quantum computing sector, while also referencing collaborations with companies like NVIDIA. Concerns around cash burn and potential dilution are being weighed against the potential for significant growth and government contracts in the burgeoning quantum computing industry.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending following news of a strategic partnership with Perplexity, an AI search company, leading to speculation about further integration of AI on the platform. The community is also focused on the high short interest in RUM and its connection to figures close to Donald Trump. Additionally, the potential acquisition of Northern Data is generating buzz around Rumble's cloud capabilities and partnership with Tether.

Aventus Network

Aventus Network ($AVT) is trending as traders discuss its low market cap, real-world partnerships with Vodafone and Heathrow, and integration with Polkadot; some community members believe $AVT is undervalued and poised for a breakout. Bullish sentiment surrounds the token, with traders closely monitoring volume as a key indicator, while also pointing to the potential of its appchain model. Some are speculating about a potential pump with a government shutdown and are hoping for new all time highs soon.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as investors discuss its price momentum and potential near-term resistance levels, with some eyeing a possible run toward $200. Community members are also weighing in on factors like AI infrastructure deals and potential government shutdowns, considering their impact on the broader market. Additionally, there's chatter around its partnerships with other companies.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

QCLS is trending due to its pivot towards quantum computing for cryptocurrency applications, generating excitement around energy-efficient blockchain infrastructure. The community is discussing the potential of LightSolver's laser-based processing units and comparing QCLS to other quantum and crypto-related stocks. Traders are monitoring the stock's threshold list status and anticipating news regarding partnerships and potential contract announcements.

A multi-agent AI platform dissecting human nature’s first principles through iterative survival challenges and data-driven insights. Core dev has access to one of the founding partners of Two Sigma Ventures - the VC company of one of the biggest hedge funds in the world. Plans to raise seed round and scale after building organic foundation. Project devs are from academia space and are trying to bridge the gap between crypto and academia.

CortexZero

CortexZero is trending amid community excitement, with many highlighting the potential for a significant breakout. Discussions are centered around its strong liquidity and the ease of access through Phantom Wallet. The token is gaining traction as a possible next mover within the Solana ecosystem.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending amid a flurry of activity in the quantum computing sector, including major acquisitions and significant funding rounds for competitors. Community members are actively discussing the potential impact of these developments on QBTS, along with its existing partnerships and recent successes in applying quantum computing to real-world problems. Bullish sentiment is fueled by the belief that QBTS is undervalued compared to peers and poised for significant growth as quantum technology gains wider adoption.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as the community rallies around the idea that everyone in crypto is Satoshi Nakamoto, celebrating the ethos of the industry's anonymous creator. Bullish sentiment is fueled by the token's strong community, its forever narrative, and the belief that it represents a second chance to get in early on crypto. Some users suggest that it has strong meme potential, like a version of $BTC.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors discuss its technical setup and potential for a rally, fueled by a recent outperformance and upcoming earnings with projected EPS growth; community talking points include the increasing short positions and the possibility of a short squeeze should a major deal, like a CiC partnership, materialize.  Also, with Sanofi now responsible for commercialization, investors are closely watching uptake and marketing efforts for Nuvaxovid, especially compared to mRNA options.

Chevron Corp. engages in the provision of administrative, financial management, and technology support for energy and chemical operations. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

CVX is trending due to geopolitical tensions in the Middle East and potential supply disruptions, driving discussions around oil prices and strategic positioning. Community members are actively monitoring the situation, with some highlighting unusual options activity and potential breakout opportunities.  Furthermore, Chevron's strategic shift into lithium production and its cost-cutting measures through global restructuring are contributing to the ongoing conversation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sanofi Q2 Earnings & Sales Miss, 2025 Top-Line View Raised, Stock Down

SNY misses Q2 earnings and sales estimates but lifts 2025 sales outlook on strong Dupixent and vaccine momentum.

Wall Street Analysts See a 26.1% Upside in Vigil Neuroscience (VIGL): Can the Stock Really Move This High?

The mean of analysts' price targets for Vigil Neuroscience (VIGL) points to a 26.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Think Vigil Neuroscience (VIGL) Could Surge 26.9%: Read This Before Placing a Bet

Should You Buy Vigil Neuroscience, Inc. (VIGL) After Golden Cross?

Wall Street Analysts Believe Vigil Neuroscience (VIGL) Could Rally 86.68%: Here's is How to Trade

Sanofi to Join Alzheimer's Space With Vigil Neuroscience Buyout

French pharmaceutical major Sanofi SA (SNY) said on Thursday that it would acquire U.S.-based Vigil Neuroscience, Inc. (VIGL) for about $470 million.Vigil is a clinical-stage biotechnology company focused on developing novel therapies for neurodegenerative diseases. The company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-21-23-15-31-3086232">said</a> the acquisition will allow Sanofi to expand its neurology pipeline.The acquisition also includes Vigil’s investigational medicine VG-3927, which is being evaluated in the treatment of Alzheimer’s disease.However, Sanofi will not acquire Vigil’s second molecule program, VGL101, being studied in patients with a rare neurodegenerative disease called Leukoencephalopathy.Under the deal, Sanofi will acquire all outstanding common shares of Vigil for $8 per share in cash at closing. This represents a 246% premium to Vigil’s closing price of $2.31 on Wednesday.Vigil’s shareholders will also receive a non-transferable contingent value right (CVR) per Vigil share, which will entitle its holder to a deferred cash payment of $2 upon the first commercial sale of VG-3927.The companies expect the transaction to close in the third quarter (Q3) of 2025, subject to customary closing conditions. The deal is not expected to have an impact on Sanofi’s financial guidance for 2025.On Stocktwits, retail sentiment around Vigil jumped from ‘bearish’ to ‘extremely bullish’ over the past 24 hours while message volume jumped from ‘low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:624/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_22_at_8_39_32_AM_png_8f74f85395.webp" alt="VIGL's Sentiment Meter and Message Volume as of 8:45 a.m. ET on May 22, 2025 | Source: Stocktwits" width="624" height="61"><figcaption>VIGL's Sentiment Meter and Message Volume as of 8:45 a.m. ET on May 22, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/VIGL">VIGL stock</a> was up about 242% in pre-market trading on Thursday. The stock has gained 31% this year but has fallen over 37% over the past 12 months.Nasdaq-listed shares of <a href="https://stocktwits.com/symbol/SNY">Sanofi</a>, meanwhile, are up by about 10% this year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/advance-auto-parts-report-upbeat-q1-earnings/ch099tRRbp1">Advance Auto Parts Stock Soars Pre-market On Upbeat Q1 Earnings: Retail Expects Rally Toward $45 Mark</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Vigil Neuroscience Stock Triples Pre-market On Acquisition By Sanofi: Retail Goes Super Bullish

Under the terms of the deal, Sanofi will acquire all outstanding common shares of Vigil for $8 per share in cash at closing.

Equity

Under the terms of the deal, Sanofi will acquire all outstanding common shares of Vigil for $8 per share in cash at closing.


SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder...

Vigil Neuroscience, Inc. engages in the provision of biotechnology research services. Its focus is improving the lives of patients, caregivers, and families affected by neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. The company was founded on June 22, 2020 and is headquartered in Watertown, MA.

Vigil Neuroscience Inc

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Current Price	$8.06
Prev Close	$8.05
Open	$8.06
Dividend Yield	0.00%
50-Day Moving Average	$7.99
Beta	0.52
Avg. Volume	765,432.00
PE Ratio	-3.85

52-Week High	$8.10
52-Week Low	$1.31
Market Capitalization	$383.88M
EPS (Annual)	-$2.07
Price to Book	9.30
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

VIGL
Vigil Neuroscience Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VIGL News

VIGL Vigil Neuroscience Inc